Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 1;37(5):560-569.
doi: 10.1097/WCO.0000000000001294. Epub 2024 Aug 22.

The genetics of amyotrophic lateral sclerosis

Affiliations
Review

The genetics of amyotrophic lateral sclerosis

Melissa Nijs et al. Curr Opin Neurol. .

Abstract

Purpose of review: Amyotrophic lateral sclerosis (ALS) has a strong genetic basis, but the genetic landscape of ALS appears to be complex. The purpose of this article is to review recent developments in the genetics of ALS.

Recent findings: Large-scale genetic studies have uncovered more than 40 genes contributing to ALS susceptibility. Both rare variants with variable effect size and more common variants with small effect size have been identified. The most common ALS genes are C9orf72 , SOD1 , TARDBP and FUS . Some of the causative genes of ALS are shared with frontotemporal dementia, confirming the molecular link between both diseases. Access to diagnostic gene testing for ALS has to improve, as effective gene silencing therapies for some genetic subtypes of ALS are emerging, but there is no consensus about which genes to test for.

Summary: Our knowledge about the genetic basis of ALS has improved and the first effective gene silencing therapies for specific genetic subtypes of ALS are underway. These therapeutic advances underline the need for better access to gene testing for people with ALS. Further research is needed to further map the genetic heterogeneity of ALS and to establish the best strategy for gene testing in a clinical setting.

PubMed Disclaimer

Conflict of interest statement

P.V.D. has served in advisory boards for Biogen, CSL Behring, Alexion Pharmaceuticals, Ferrer, QurAlis, Cytokinetics, Argenx, UCB, Muna Therapeutics, Alector, Augustine Therapeutics, VectorY, Zambon, Amylyx, Sapreme Technologies, Novartis (paid to institution). P.V.D. has received speaker fees from Biogen and Amylyx (paid to institution).

Figures

Box 1
Box 1
no caption available
FIGURE 1
FIGURE 1
Overview of most important ALS-related genes and their roles in motor neurons. (a) NEK1 and C21orf2 play a role in ciliogenesis and cilia maintenance. (b) VCP, TBK1, C9orf72, UBQLN1, SQSTM1, VAPB, CHMP2B, ANXA11, SIGMAR1, OPTN, FIG4, ALS2 and CCNF are involved in the proteasomal and/or autophagy-mediated degradation of misfolded proteins. (c) CHCHD10, SOD1 and TDP-43 are involved in the regulation of mitochondrial dynamics. (d) FUS, TDP-43, NEK1 and C21orf2 facilitate DNA repair. (e) TDP-43, FUS, ANG, SETX, HNRNPA1/A2B1, MATR3, ATXN2 and TIA-1 regulate the RNA metabolism of motor neurons at various levels. (f) ALS2, PFN1, NEFH, PRPH, TUBA4A, SPG11 and NEK1 contribute to the assembly and/or stability of cytoskeletal components. KIF5A and DCTN1 are key players in bidirectional axonal transport. Hh, hedgehog; SMO, Smoothened receptor; UPS, ubiquitin-proteasome system; SG, stress granule; pri-miRNA, primary microRNA; premiRNA, precursor microRNA. Figure created with BioRender.com.

Similar articles

Cited by

References

    1. Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 2020; 27:1918–1929. - PMC - PubMed
    1. Van Damme P, Al-Chalabi A, Andersen PM, et al. . European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD). Eur J Neurol 2024; 31:e16264. - PMC - PubMed
    1. Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 2007; 6:994–1003. - PubMed
    1. Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362:59–62. - PubMed
    1. Al-Chalabi A, van den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol 2017; 13:96–104. - PubMed

MeSH terms